CEBP CTRC-AACR San Antonio Breast Cancer Symposium Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tseng, M.
Right arrow Articles by McGlynn, K. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tseng, M.
Right arrow Articles by McGlynn, K. A.
Cancer Epidemiology Biomarkers & Prevention Vol. 9, 625-630, June 2000
© 2000 American Association for Cancer Research

Serum Ferritin Concentration and Recurrence of Colorectal Adenoma

Marilyn Tseng1, E. Robert Greenberg, Robert S. Sandler, John A. Baron, Robert W. Haile, Baruch S. Blumberg and Katherine A. McGlynn

Epidemiology Branch, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709 [M. T.]; Departments of Medicine and Community and Family Medicine and Norris Cotton Cancer Center, Dartmouth Medical School, Hanover, New Hampshire 03755 [E. R. G., J. A. B.]; Center for Gastrointestinal Biology and Disease, University of North Carolina, Chapel Hill, North Carolina 27599 [R. S. S.]; Department of Preventive Medicine, School of Medicine, University of Southern California, Los Angeles, California 90033 [R. W. H.]; Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111 [B. S. B.]; and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892 [K. A. M.]

Both body iron stores and dietary iron intake have been reported to increase risk of colorectal neoplasms. We assessed whether serum ferritin concentration was associated with recurrence of colorectal adenomas among 733 individuals with baseline determinations of ferritin as part of a multicenter clinical trial of antioxidant supplements for adenoma prevention. All study participants had at least one adenoma removed within 3 months before enrollment, and 269 of them developed one or more adenomas between follow-up colonoscopies conducted 1 and 4 years after enrollment. Baseline serum ferritin concentrations were analyzed both as a log-transformed continuous variable and as a categorical variable, defined as whether iron stores were nonreplete and low (ferritin <=30 µg/liter), nonreplete and borderline (31–70 µg/liter), replete and adequate (71–160 µg/liter), or replete and high (>160 µg/liter). Analyses were based on multiple logistic regression models, including age, sex, study center, energy, alcohol, fiber, folate, and total fat intake, number of months between colonoscopic examinations, smoking status, and aspirin use. Overall, there was no statistically significant linear association between log ferritin concentration and adenoma recurrence (P = 0.33). Risk of adenoma recurrence was modestly increased among participants with ferritin concentrations >70 µg/liter relative to those with lower ferritin (odds ratio, 1.39; 95% confidence interval, 0.96–2.02). This result seemed more pronounced among women than men. Dietary intake of iron and red meat was inversely associated with adenoma recurrence among participants with replete iron stores but not consistently associated among those with nonreplete stores. Our findings suggest that any role of iron stores and dietary iron in influencing risk of colorectal adenoma recurrence is likely complex.




This article has been cited by other articles:


Home page
JNCI J Natl Cancer InstHome page
A. T. Chan, J. Ma, G. J. Tranah, E. L. Giovannucci, N. Rifai, D. J. Hunter, and C. S. Fuchs
Hemochromatosis Gene Mutations, Body Iron Stores, Dietary Iron, and Risk of Colorectal Adenoma in Women
J Natl Cancer Inst, June 15, 2005; 97(12): 917 - 926.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
K. A. McGlynn, L. C. Sakoda, Y. Hu, R. E. Schoen, R. S. Bresalier, M. Yeager, S. Chanock, R. B. Hayes, and K. H. Buetow
Hemochromatosis Gene Mutations and Distal Adenomatous Colorectal Polyps
Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 158 - 163.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
N. J. Shaheen, L. M. Silverman, T. Keku, L. B. Lawrence, E. M. Rohlfs, C. F. Martin, J. Galanko, and R. S. Sandler
Association Between Hemochromatosis (HFE) Gene Mutation Carrier Status and the Risk of Colon Cancer
J Natl Cancer Inst, January 15, 2003; 95(2): 154 - 159.
[Abstract] [Full Text] [PDF]


Home page
Br Med BullHome page
P. Boyle and M. E. Leon
Epidemiology of colorectal cancer
Br. Med. Bull., December 1, 2002; 64(1): 1 - 25.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.